[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2403995A - Methods and compositions to enhance endogenous fibrinolytic activity - Google Patents

Methods and compositions to enhance endogenous fibrinolytic activity

Info

Publication number
AU2403995A
AU2403995A AU24039/95A AU2403995A AU2403995A AU 2403995 A AU2403995 A AU 2403995A AU 24039/95 A AU24039/95 A AU 24039/95A AU 2403995 A AU2403995 A AU 2403995A AU 2403995 A AU2403995 A AU 2403995A
Authority
AU
Australia
Prior art keywords
compositions
methods
fibrinolytic activity
enhance endogenous
endogenous fibrinolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24039/95A
Inventor
Jack Hirsh
Thomas J Podor
Jeffrey I Weitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamilton Civic Hospitals Research Development Inc
Original Assignee
Hamilton Civic Hospitals Research Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamilton Civic Hospitals Research Development Inc filed Critical Hamilton Civic Hospitals Research Development Inc
Publication of AU2403995A publication Critical patent/AU2403995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU24039/95A 1994-05-10 1995-05-10 Methods and compositions to enhance endogenous fibrinolytic activity Abandoned AU2403995A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US240377 1981-03-04
US24037794A 1994-05-10 1994-05-10
PCT/CA1995/000279 WO1995030438A2 (en) 1994-05-10 1995-05-10 Methods and compositions to enhance endogenous fibrinolytic activity

Publications (1)

Publication Number Publication Date
AU2403995A true AU2403995A (en) 1995-11-29

Family

ID=22906285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24039/95A Abandoned AU2403995A (en) 1994-05-10 1995-05-10 Methods and compositions to enhance endogenous fibrinolytic activity

Country Status (2)

Country Link
AU (1) AU2403995A (en)
WO (1) WO1995030438A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051085A1 (en) * 2000-01-14 2001-07-19 Tanox, Inc. Use of antagonists of plasminogen activator inhibitor-1 (pai-1) for the treatment of asthma and chronic obstructive pulmonary disease
EP2566890A4 (en) * 2010-05-03 2013-11-20 Abbvie Inc Anti-pai-1 antibodies and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2101614A1 (en) * 1992-07-30 1994-01-31 Shmuel Shaltiel Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
WO1995030438A3 (en) 1996-01-25
WO1995030438A2 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU4081489A (en) Fatty acid therapy and compositions
AU6559690A (en) Methods and compositions employing certain lysozymes and endoglycosidases
AU1928188A (en) Dust suppression methods and compositions
AU3671099A (en) Methods and compositions pertaining to pd-loops
AU1532297A (en) Starch-emulsifier composition and methods of making
AU3770589A (en) Enzymatic dishwashing and rinsing composition
AU3008089A (en) Silyl 2-amidoacetate and silyl 3-amidopropionate compositions
AU5828098A (en) Texture and stabilizer composition
AU4057197A (en) Composition to aid in the forming of metal
AU9301998A (en) Composition and methods using galectin-1
AU7134598A (en) Plant propagation compositions and methods
AU1939895A (en) Enzymatic debridement compositions and methods
AU3805593A (en) Phosphate selective composition and electrode
AU4605489A (en) Enzyme-containing detergent compositions and their use
AU8671798A (en) Methods and compositions relating to no-mediated cytotoxicity
AU4895297A (en) Methods and compositions for enhancing the expression of genes in plants
AU4024289A (en) Selenium-sulfur compositions and uses therefor
AU2403995A (en) Methods and compositions to enhance endogenous fibrinolytic activity
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU4581193A (en) Improvements in and relating to dentistry
AU4579793A (en) Improvements in and relating to biscuits
AU7599287A (en) Silica aerogels and dentifrice composition
AU1408499A (en) Compositions and methods to prevent turkey enteritis